Scribd
Upload
32 views

Acc Project Introduction

Cipla is a global pharmaceutical company established in 1935 focused on agile growth and making medicines accessible. It has a portfolio of complex generics and drugs across many therapeutic areas. Cipla has 47 manufacturing sites worldwide producing over 1,500 products for 86 markets. Cipla aims to be carbon neutral and zero waste by 2025 and ensure employee well-being and partnerships. As a responsible company, Cipla's humanitarian approach to healthcare and community links make it a partner of choice for global health organizations.

Uploaded by

Ayush K Patel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
32 views

Acc Project Introduction

Cipla is a global pharmaceutical company established in 1935 focused on agile growth and making medicines accessible. It has a portfolio of complex generics and drugs across many therapeutic areas. Cipla has 47 manufacturing sites worldwide producing over 1,500 products for 86 markets. Cipla aims to be carbon neutral and zero waste by 2025 and ensure employee well-being and partnerships. As a responsible company, Cipla's humanitarian approach to healthcare and community links make it a partner of choice for global health organizations.

Uploaded by

Ayush K Patel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Corporate Overview & Integrated Report Statutory Reports Financial Statements

003

About Cipla1

Established in 1935, Cipla is a global pharmaceutical company focused on agile


and sustainable growth with a firm commitment to make medicines accessible and
available to those in need.
Our product portfolio spans complex generics as well as drugs in the respiratory,
anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key
therapeutic segments. With a rich portfolio, we are deepening our presence in
the home markets of India, as well as South Africa, North America, and other key
regulated and emerging markets. Our 47 manufacturing sites around the world
produce 50+ dosage forms and 1,500+ products using cutting-edge technology
platforms to cater to our 86 markets2 .

For over eight decades, making a and strong financial growth, provide a
difference to patients has inspired every robust foundation to build a responsible
aspect of Cipla’s work. Our paradigm- business and stay committed to
changing offer of a triple anti-retroviral sustainable growth.
therapy in HIV/AIDS at less than a
dollar a day in Africa in 2001 is widely By 2025, Cipla endeavours
acknowledged as having contributed to to be a carbon neutral,
bringing inclusiveness, accessibility and water neutral and zero
affordability to the centre of the
waste to landfill Company.
HIV movement.
Cipla also aims to attain
Cipla is the third-largest AMR stewardship, green
pharmaceutical Company chemistry and making
in India and the third it right and ensure well-
largest in the private being of employees and
pharmaceutical market of partners.
South Africa (IQVIA, As a responsible corporate citizen,
March 2022). Cipla’s humanitarian approach to
healthcare in pursuit of its purpose
We are the second of ‘Caring for Life’ and deep-rooted
largest Indian exporter community linkages to wherever it is
to emerging markets 3 present, makes it a partner of choice to
global health bodies, peers and
and also among the most
all stakeholders.
dispensed generic players
in the US. Our approach to For more, please visit
responsible resource consumption, www.cipla.com or click on
efforts to enhance access and Twitter, Facebook and
affordability of medicines worldwide LinkedIn channels.

1
GRI 102-1, GRI 102-2 , GRI 102-5, GRI 102-6, GRI 102-12
2
Represents countries / markets where sales are more than USD 0.5 million
3
EXIM Intellimax data for Emerging Markets (ex SAGA, CIS, China) for FY 2021-22

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy